Listed

Jasper Therapeutics, Inc.

JSPRNasdaqCIK 1788028HealthcareFiscal year ends Dec 31

Share

Share this page

Story card, 1080 × 1920

Standardized line items from XBRL company facts, the last twelve quarters. Negative values are in parentheses. A figure marked d is derived from year-to-date figures.

Income statement

Operating income−$9.2m, Q2 FY2026
Net income−$2.8m, Q2 FY2026
Line itemUnitQ3 FY20232023-09-30Q4 FY20232023-12-31Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30Q4 FY20242024-12-31Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30Q4 FY20252025-12-31Q1 FY20262026-03-31Q2 FY20262026-06-30
Cost of revenue$mnot reportednot reportednot reportednot reported8.8Cost of revenue, Q3 FY2024, three months to 2024-09-30$8.8m. XBRL concept us-gaap:CostOfRevenue. 10-Q filed 2025-11-10, accession 0001213900-25-107884.Report this figure13.2Cost of revenue, Q4 FY2024, three months to 2024-12-31$13.2m. XBRL concept us-gaap:CostOfRevenue. 10-K filed 2026-03-30, accession 0001213900-26-036426. Derived: 12-month figure less the 9-month figure.Report this figure9.8Cost of revenue, Q1 FY2025, three months to 2025-03-31$9.8m. XBRL concept us-gaap:CostOfRevenue. 10-Q filed 2026-05-14, accession 0001213900-26-056595.Report this figure15.8Cost of revenue, Q2 FY2025, three months to 2025-06-30$15.8m. XBRL concept us-gaap:CostOfRevenue. 10-Q filed 2026-08-14, accession 0001213900-26-089592.Report this figure9.3Cost of revenue, Q3 FY2025, three months to 2025-09-30$9.3m. XBRL concept us-gaap:CostOfRevenue. 10-Q filed 2025-11-10, accession 0001213900-25-107884.Report this figure6.8Cost of revenue, Q4 FY2025, three months to 2025-12-31$6.8m. XBRL concept us-gaap:CostOfRevenue. 10-K filed 2026-03-30, accession 0001213900-26-036426. Derived: 12-month figure less the 9-month figure.Report this figure3.6Cost of revenue, Q1 FY2026, three months to 2026-03-31$3.6m. XBRL concept us-gaap:CostOfRevenue. 10-Q filed 2026-05-14, accession 0001213900-26-056595.Report this figure3.6Cost of revenue, Q2 FY2026, three months to 2026-06-30$3.6m. XBRL concept us-gaap:CostOfRevenue. 10-Q filed 2026-08-14, accession 0001213900-26-089592.Report this figure
Research and development$m14.8Research and development, Q3 FY2023, three months to 2023-09-30$14.8m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2024-11-07, accession 0001213900-24-095173.Report this figure13.8Research and development, Q4 FY2023, three months to 2023-12-31$13.8m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-K filed 2025-02-28, accession 0001213900-25-018384. Derived: 12-month figure less the 9-month figure.Report this figure10.3Research and development, Q1 FY2024, three months to 2024-03-31$10.3m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-05-12, accession 0001213900-25-042011.Report this figure11.3Research and development, Q2 FY2024, three months to 2024-06-30$11.3m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-08-13, accession 0001213900-25-075635.Report this figure14.5Research and development, Q3 FY2024, three months to 2024-09-30$14.5m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-11-10, accession 0001213900-25-107884.Report this figure19.8Research and development, Q4 FY2024, three months to 2024-12-31$19.8m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-K filed 2026-03-30, accession 0001213900-26-036426. Derived: 12-month figure less the 9-month figure.Report this figure16.2Research and development, Q1 FY2025, three months to 2025-03-31$16.2m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-05-14, accession 0001213900-26-056595.Report this figure21.2Research and development, Q2 FY2025, three months to 2025-06-30$21.2m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-08-14, accession 0001213900-26-089592.Report this figure14.4Research and development, Q3 FY2025, three months to 2025-09-30$14.4m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-11-10, accession 0001213900-25-107884.Report this figure11.4Research and development, Q4 FY2025, three months to 2025-12-31$11.4m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-K filed 2026-03-30, accession 0001213900-26-036426. Derived: 12-month figure less the 9-month figure.Report this figure5.8Research and development, Q1 FY2026, three months to 2026-03-31$5.8m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-05-14, accession 0001213900-26-056595.Report this figure5.1Research and development, Q2 FY2026, three months to 2026-06-30$5.1m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-08-14, accession 0001213900-26-089592.Report this figure
Operating income$m(19.4)Operating income, Q3 FY2023, three months to 2023-09-30−$19.4m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2024-11-07, accession 0001213900-24-095173.Report this figure(17.7)Operating income, Q4 FY2023, three months to 2023-12-31−$17.7m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2025-02-28, accession 0001213900-25-018384. Derived: 12-month figure less the 9-month figure.Report this figure(15.1)Operating income, Q1 FY2024, three months to 2024-03-31−$15.1m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-05-12, accession 0001213900-25-042011.Report this figure(16.0)Operating income, Q2 FY2024, three months to 2024-06-30−$16.0m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-08-13, accession 0001213900-25-075635.Report this figure(19.9)Operating income, Q3 FY2024, three months to 2024-09-30−$19.9m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-11-10, accession 0001213900-25-107884.Report this figure(25.3)Operating income, Q4 FY2024, three months to 2024-12-31−$25.3m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-03-30, accession 0001213900-26-036426. Derived: 12-month figure less the 9-month figure.Report this figure(21.8)Operating income, Q1 FY2025, three months to 2025-03-31−$21.8m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-05-14, accession 0001213900-26-056595.Report this figure(27.1)Operating income, Q2 FY2025, three months to 2025-06-30−$27.1m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-08-14, accession 0001213900-26-089592.Report this figure(19.2)Operating income, Q3 FY2025, three months to 2025-09-30−$19.2m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-11-10, accession 0001213900-25-107884.Report this figure(15.8)Operating income, Q4 FY2025, three months to 2025-12-31−$15.8m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-03-30, accession 0001213900-26-036426. Derived: 12-month figure less the 9-month figure.Report this figure(11.0)Operating income, Q1 FY2026, three months to 2026-03-31−$11.0m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-05-14, accession 0001213900-26-056595.Report this figure(9.2)Operating income, Q2 FY2026, three months to 2026-06-30−$9.2m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-08-14, accession 0001213900-26-089592.Report this figure
Income tax$mnot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reported
Net income$m(17.5)Net income, Q3 FY2023, three months to 2023-09-30−$17.5m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2024-11-07, accession 0001213900-24-095173.Report this figure(16.6)Net income, Q4 FY2023, three months to 2023-12-31−$16.6m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2025-02-28, accession 0001213900-25-018384. Derived: 12-month figure less the 9-month figure.Report this figure(13.7)Net income, Q1 FY2024, three months to 2024-03-31−$13.7m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-05-12, accession 0001213900-25-042011.Report this figure(14.6)Net income, Q2 FY2024, three months to 2024-06-30−$14.6m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-08-13, accession 0001213900-25-075635.Report this figure(18.6)Net income, Q3 FY2024, three months to 2024-09-30−$18.6m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-11-10, accession 0001213900-25-107884.Report this figure(24.3)Net income, Q4 FY2024, three months to 2024-12-31−$24.3m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-03-30, accession 0001213900-26-036426. Derived: 12-month figure less the 9-month figure.Report this figure(21.2)Net income, Q1 FY2025, three months to 2025-03-31−$21.2m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-05-14, accession 0001213900-26-056595.Report this figure(26.7)Net income, Q2 FY2025, three months to 2025-06-30−$26.7m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-14, accession 0001213900-26-089592.Report this figure(18.7)Net income, Q3 FY2025, three months to 2025-09-30−$18.7m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-11-10, accession 0001213900-25-107884.Report this figure(9.1)Net income, Q4 FY2025, three months to 2025-12-31−$9.1m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-03-30, accession 0001213900-26-036426. Derived: 12-month figure less the 9-month figure.Report this figure(1.2)Net income, Q1 FY2026, three months to 2026-03-31−$1.2m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-05-14, accession 0001213900-26-056595.Report this figure(2.8)Net income, Q2 FY2026, three months to 2026-06-30−$2.8m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-14, accession 0001213900-26-089592.Report this figure
Diluted EPS$ per share(1.60)Diluted EPS, Q3 FY2023, three months to 2023-09-30−$1.60 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2024-11-07, accession 0001213900-24-095173.Report this figurenot reported(1.03)Diluted EPS, Q1 FY2024, three months to 2024-03-31−$1.03 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-05-12, accession 0001213900-25-042011.Report this figure(0.97)Diluted EPS, Q2 FY2024, three months to 2024-06-30−$0.97 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-08-13, accession 0001213900-25-075635.Report this figure(1.24)Diluted EPS, Q3 FY2024, three months to 2024-09-30−$1.24 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-11-10, accession 0001213900-25-107884.Report this figurenot reported(1.41)Diluted EPS, Q1 FY2025, three months to 2025-03-31−$1.41 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-05-14, accession 0001213900-26-056595.Report this figure(1.74)Diluted EPS, Q2 FY2025, three months to 2025-06-30−$1.74 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-08-14, accession 0001213900-26-089592.Report this figure(1.13)Diluted EPS, Q3 FY2025, three months to 2025-09-30−$1.13 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-11-10, accession 0001213900-25-107884.Report this figurenot reported(0.04)Diluted EPS, Q1 FY2026, three months to 2026-03-31−$0.04 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-05-14, accession 0001213900-26-056595.Report this figure(0.10)Diluted EPS, Q2 FY2026, three months to 2026-06-30−$0.10 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-08-14, accession 0001213900-26-089592.Report this figure
Basic EPS$ per share(1.60)Basic EPS, Q3 FY2023, three months to 2023-09-30−$1.60 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2024-11-07, accession 0001213900-24-095173.Report this figurenot reported(1.03)Basic EPS, Q1 FY2024, three months to 2024-03-31−$1.03 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-05-12, accession 0001213900-25-042011.Report this figure(0.97)Basic EPS, Q2 FY2024, three months to 2024-06-30−$0.97 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-08-13, accession 0001213900-25-075635.Report this figure(1.24)Basic EPS, Q3 FY2024, three months to 2024-09-30−$1.24 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-11-10, accession 0001213900-25-107884.Report this figurenot reported(1.41)Basic EPS, Q1 FY2025, three months to 2025-03-31−$1.41 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-05-14, accession 0001213900-26-056595.Report this figure(1.74)Basic EPS, Q2 FY2025, three months to 2025-06-30−$1.74 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-08-14, accession 0001213900-26-089592.Report this figure(1.13)Basic EPS, Q3 FY2025, three months to 2025-09-30−$1.13 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-11-10, accession 0001213900-25-107884.Report this figurenot reported(0.04)Basic EPS, Q1 FY2026, three months to 2026-03-31−$0.04 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-05-14, accession 0001213900-26-056595.Report this figure(0.10)Basic EPS, Q2 FY2026, three months to 2026-06-30−$0.10 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-08-14, accession 0001213900-26-089592.Report this figure

Balance sheet

Cash and equivalents$7.3m, Q2 FY2026
Shareholders' equity$1.4m, Q2 FY2026
Line itemUnitQ3 FY20232023-09-30FY20232023-12-31Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30FY20242024-12-31Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30FY20252025-12-31Q1 FY20262026-03-31Q2 FY20262026-06-30
Cash and equivalents$m104Cash and equivalents, Q3 FY2023, at 2023-09-30$103.9m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2023-11-09, accession 0001213900-23-084970.Report this figure86.9Cash and equivalents, FY2023, at 2023-12-31$86.9m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-K filed 2025-02-28, accession 0001213900-25-018384.Report this figure118Cash and equivalents, Q1 FY2024, at 2024-03-31$118.5m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2024-05-14, accession 0001213900-24-042805.Report this figure107Cash and equivalents, Q2 FY2024, at 2024-06-30$106.8m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2024-08-13, accession 0001213900-24-067897.Report this figure92.5Cash and equivalents, Q3 FY2024, at 2024-09-30$92.5m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2024-11-07, accession 0001213900-24-095173.Report this figure71.6Cash and equivalents, FY2024, at 2024-12-31$71.6m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-K filed 2026-03-30, accession 0001213900-26-036426.Report this figure48.8Cash and equivalents, Q1 FY2025, at 2025-03-31$48.8m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2025-05-12, accession 0001213900-25-042011.Report this figure39.5Cash and equivalents, Q2 FY2025, at 2025-06-30$39.5m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2025-08-13, accession 0001213900-25-075635.Report this figure50.9Cash and equivalents, Q3 FY2025, at 2025-09-30$50.9m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2025-11-10, accession 0001213900-25-107884.Report this figure28.7Cash and equivalents, FY2025, at 2025-12-31$28.7m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-08-14, accession 0001213900-26-089592.Report this figure14.1Cash and equivalents, Q1 FY2026, at 2026-03-31$14.1m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-05-14, accession 0001213900-26-056595.Report this figure7.3Cash and equivalents, Q2 FY2026, at 2026-06-30$7.3m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-08-14, accession 0001213900-26-089592.Report this figure
Current assets$m105Current assets, Q3 FY2023, at 2023-09-30$105.2m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2023-11-09, accession 0001213900-23-084970.Report this figure88.9Current assets, FY2023, at 2023-12-31$88.9m. XBRL concept us-gaap:AssetsCurrent. 10-K filed 2025-02-28, accession 0001213900-25-018384.Report this figure120Current assets, Q1 FY2024, at 2024-03-31$120.3m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2024-05-14, accession 0001213900-24-042805.Report this figure109Current assets, Q2 FY2024, at 2024-06-30$108.7m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2024-08-13, accession 0001213900-24-067897.Report this figure94.8Current assets, Q3 FY2024, at 2024-09-30$94.8m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2024-11-07, accession 0001213900-24-095173.Report this figure75.8Current assets, FY2024, at 2024-12-31$75.8m. XBRL concept us-gaap:AssetsCurrent. 10-K filed 2026-03-30, accession 0001213900-26-036426.Report this figure53.2Current assets, Q1 FY2025, at 2025-03-31$53.2m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2025-05-12, accession 0001213900-25-042011.Report this figure43.0Current assets, Q2 FY2025, at 2025-06-30$43.0m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2025-08-13, accession 0001213900-25-075635.Report this figure54.6Current assets, Q3 FY2025, at 2025-09-30$54.6m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2025-11-10, accession 0001213900-25-107884.Report this figure34.6Current assets, FY2025, at 2025-12-31$34.6m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2026-08-14, accession 0001213900-26-089592.Report this figure20.3Current assets, Q1 FY2026, at 2026-03-31$20.3m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2026-05-14, accession 0001213900-26-056595.Report this figure11.6Current assets, Q2 FY2026, at 2026-06-30$11.6m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2026-08-14, accession 0001213900-26-089592.Report this figure
Total assets$m110Total assets, Q3 FY2023, at 2023-09-30$110.4m. XBRL concept us-gaap:Assets. 10-Q filed 2023-11-09, accession 0001213900-23-084970.Report this figure94.9Total assets, FY2023, at 2023-12-31$94.9m. XBRL concept us-gaap:Assets. 10-K filed 2025-02-28, accession 0001213900-25-018384.Report this figure126Total assets, Q1 FY2024, at 2024-03-31$126.0m. XBRL concept us-gaap:Assets. 10-Q filed 2024-05-14, accession 0001213900-24-042805.Report this figure114Total assets, Q2 FY2024, at 2024-06-30$113.9m. XBRL concept us-gaap:Assets. 10-Q filed 2024-08-13, accession 0001213900-24-067897.Report this figure99.4Total assets, Q3 FY2024, at 2024-09-30$99.4m. XBRL concept us-gaap:Assets. 10-Q filed 2024-11-07, accession 0001213900-24-095173.Report this figure79.9Total assets, FY2024, at 2024-12-31$79.9m. XBRL concept us-gaap:Assets. 10-K filed 2026-03-30, accession 0001213900-26-036426.Report this figure57.6Total assets, Q1 FY2025, at 2025-03-31$57.6m. XBRL concept us-gaap:Assets. 10-Q filed 2025-05-12, accession 0001213900-25-042011.Report this figure46.5Total assets, Q2 FY2025, at 2025-06-30$46.5m. XBRL concept us-gaap:Assets. 10-Q filed 2025-08-13, accession 0001213900-25-075635.Report this figure57.5Total assets, Q3 FY2025, at 2025-09-30$57.5m. XBRL concept us-gaap:Assets. 10-Q filed 2025-11-10, accession 0001213900-25-107884.Report this figure35.8Total assets, FY2025, at 2025-12-31$35.8m. XBRL concept us-gaap:Assets. 10-Q filed 2026-08-14, accession 0001213900-26-089592.Report this figure21.2Total assets, Q1 FY2026, at 2026-03-31$21.2m. XBRL concept us-gaap:Assets. 10-Q filed 2026-05-14, accession 0001213900-26-056595.Report this figure11.8Total assets, Q2 FY2026, at 2026-06-30$11.8m. XBRL concept us-gaap:Assets. 10-Q filed 2026-08-14, accession 0001213900-26-089592.Report this figure
Current liabilities$m11.9Current liabilities, Q3 FY2023, at 2023-09-30$11.9m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2023-11-09, accession 0001213900-23-084970.Report this figure12.4Current liabilities, FY2023, at 2023-12-31$12.4m. XBRL concept us-gaap:LiabilitiesCurrent. 10-K filed 2025-02-28, accession 0001213900-25-018384.Report this figure8.9Current liabilities, Q1 FY2024, at 2024-03-31$8.9m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2024-05-14, accession 0001213900-24-042805.Report this figure10.1Current liabilities, Q2 FY2024, at 2024-06-30$10.1m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2024-08-13, accession 0001213900-24-067897.Report this figure12.5Current liabilities, Q3 FY2024, at 2024-09-30$12.5m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2024-11-07, accession 0001213900-24-095173.Report this figure15.2Current liabilities, FY2024, at 2024-12-31$15.2m. XBRL concept us-gaap:LiabilitiesCurrent. 10-K filed 2026-03-30, accession 0001213900-26-036426.Report this figure12.3Current liabilities, Q1 FY2025, at 2025-03-31$12.3m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2025-05-12, accession 0001213900-25-042011.Report this figure20.5Current liabilities, Q2 FY2025, at 2025-06-30$20.5m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2025-08-13, accession 0001213900-25-075635.Report this figure21.0Current liabilities, Q3 FY2025, at 2025-09-30$21.0m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2025-11-10, accession 0001213900-25-107884.Report this figure13.2Current liabilities, FY2025, at 2025-12-31$13.2m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2026-08-14, accession 0001213900-26-089592.Report this figure9.0Current liabilities, Q1 FY2026, at 2026-03-31$9.0m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2026-05-14, accession 0001213900-26-056595.Report this figure7.8Current liabilities, Q2 FY2026, at 2026-06-30$7.8m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2026-08-14, accession 0001213900-26-089592.Report this figure
Total liabilities$m16.3Total liabilities, Q3 FY2023, at 2023-09-30$16.3m. XBRL concept us-gaap:Liabilities. 10-Q filed 2023-11-09, accession 0001213900-23-084970.Report this figure16.5Total liabilities, FY2023, at 2023-12-31$16.5m. XBRL concept us-gaap:Liabilities. 10-K filed 2025-02-28, accession 0001213900-25-018384.Report this figure12.7Total liabilities, Q1 FY2024, at 2024-03-31$12.7m. XBRL concept us-gaap:Liabilities. 10-Q filed 2024-05-14, accession 0001213900-24-042805.Report this figure13.6Total liabilities, Q2 FY2024, at 2024-06-30$13.6m. XBRL concept us-gaap:Liabilities. 10-Q filed 2024-08-13, accession 0001213900-24-067897.Report this figure15.7Total liabilities, Q3 FY2024, at 2024-09-30$15.7m. XBRL concept us-gaap:Liabilities. 10-Q filed 2024-11-07, accession 0001213900-24-095173.Report this figure18.2Total liabilities, FY2024, at 2024-12-31$18.2m. XBRL concept us-gaap:Liabilities. 10-K filed 2026-03-30, accession 0001213900-26-036426.Report this figure15.4Total liabilities, Q1 FY2025, at 2025-03-31$15.4m. XBRL concept us-gaap:Liabilities. 10-Q filed 2025-05-12, accession 0001213900-25-042011.Report this figure23.0Total liabilities, Q2 FY2025, at 2025-06-30$23.0m. XBRL concept us-gaap:Liabilities. 10-Q filed 2025-08-13, accession 0001213900-25-075635.Report this figure45.9Total liabilities, Q3 FY2025, at 2025-09-30$45.9m. XBRL concept us-gaap:Liabilities. 10-Q filed 2025-11-10, accession 0001213900-25-107884.Report this figure31.6Total liabilities, FY2025, at 2025-12-31$31.6m. XBRL concept us-gaap:Liabilities. 10-Q filed 2026-08-14, accession 0001213900-26-089592.Report this figure17.8Total liabilities, Q1 FY2026, at 2026-03-31$17.8m. XBRL concept us-gaap:Liabilities. 10-Q filed 2026-05-14, accession 0001213900-26-056595.Report this figure10.4Total liabilities, Q2 FY2026, at 2026-06-30$10.4m. XBRL concept us-gaap:Liabilities. 10-Q filed 2026-08-14, accession 0001213900-26-089592.Report this figure
Shareholders' equity$m94.1Shareholders' equity, Q3 FY2023, at 2023-09-30$94.1m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2024-11-07, accession 0001213900-24-095173.Report this figure78.4Shareholders' equity, FY2023, at 2023-12-31$78.4m. XBRL concept us-gaap:StockholdersEquity. 10-K filed 2026-03-30, accession 0001213900-26-036426.Report this figure113Shareholders' equity, Q1 FY2024, at 2024-03-31$113.2m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-08-13, accession 0001213900-25-075635.Report this figure100Shareholders' equity, Q2 FY2024, at 2024-06-30$100.3m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-11-10, accession 0001213900-25-107884.Report this figure83.7Shareholders' equity, Q3 FY2024, at 2024-09-30$83.7m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-11-10, accession 0001213900-25-107884.Report this figure61.7Shareholders' equity, FY2024, at 2024-12-31$61.7m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-14, accession 0001213900-26-089592.Report this figure42.2Shareholders' equity, Q1 FY2025, at 2025-03-31$42.2m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-14, accession 0001213900-26-089592.Report this figure23.5Shareholders' equity, Q2 FY2025, at 2025-06-30$23.5m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-14, accession 0001213900-26-089592.Report this figure11.6Shareholders' equity, Q3 FY2025, at 2025-09-30$11.6m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-11-10, accession 0001213900-25-107884.Report this figure4.2Shareholders' equity, FY2025, at 2025-12-31$4.2m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-14, accession 0001213900-26-089592.Report this figure3.4Shareholders' equity, Q1 FY2026, at 2026-03-31$3.4m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-14, accession 0001213900-26-089592.Report this figure1.4Shareholders' equity, Q2 FY2026, at 2026-06-30$1.4m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-14, accession 0001213900-26-089592.Report this figure

Cash flow

Operating cash flow−$6.9m, Q2 FY2026
Line itemUnitQ3 FY20232023-09-30Q4 FY20232023-12-31Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30Q4 FY20242024-12-31Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30Q4 FY20252025-12-31Q1 FY20262026-03-31Q2 FY20262026-06-30
Operating cash flow$m(12.0)Operating cash flow, Q3 FY2023, three months to 2023-09-30−$12.0m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2024-11-07, accession 0001213900-24-095173. Derived: 9-month figure less the 6-month figure.Report this figure(16.5)Operating cash flow, Q4 FY2023, three months to 2023-12-31−$16.5m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2025-02-28, accession 0001213900-25-018384. Derived: 12-month figure less the 9-month figure.Report this figure(15.7)Operating cash flow, Q1 FY2024, three months to 2024-03-31−$15.7m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-05-12, accession 0001213900-25-042011.Report this figure(11.7)Operating cash flow, Q2 FY2024, three months to 2024-06-30−$11.7m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-08-13, accession 0001213900-25-075635. Derived: 6-month figure less the 3-month figure.Report this figure(14.1)Operating cash flow, Q3 FY2024, three months to 2024-09-30−$14.1m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-11-10, accession 0001213900-25-107884. Derived: 9-month figure less the 6-month figure.Report this figure(21.1)Operating cash flow, Q4 FY2024, three months to 2024-12-31−$21.1m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-03-30, accession 0001213900-26-036426. Derived: 12-month figure less the 9-month figure.Report this figure(22.8)Operating cash flow, Q1 FY2025, three months to 2025-03-31−$22.8m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-05-14, accession 0001213900-26-056595.Report this figure(15.5)Operating cash flow, Q2 FY2025, three months to 2025-06-30−$15.5m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-08-14, accession 0001213900-26-089592. Derived: 6-month figure less the 3-month figure.Report this figure(17.0)Operating cash flow, Q3 FY2025, three months to 2025-09-30−$17.0m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-11-10, accession 0001213900-25-107884. Derived: 9-month figure less the 6-month figure.Report this figure(21.9)Operating cash flow, Q4 FY2025, three months to 2025-12-31−$21.9m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-03-30, accession 0001213900-26-036426. Derived: 12-month figure less the 9-month figure.Report this figure(14.5)Operating cash flow, Q1 FY2026, three months to 2026-03-31−$14.5m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-05-14, accession 0001213900-26-056595.Report this figure(6.9)Operating cash flow, Q2 FY2026, three months to 2026-06-30−$6.9m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-08-14, accession 0001213900-26-089592. Derived: 6-month figure less the 3-month figure.Report this figure

Shares

Diluted shares (weighted)28.70m, Q2 FY2026
Line itemUnitQ3 FY20222022-09-30Q1 FY20232023-03-31Q2 FY20232023-06-30Q3 FY20232023-09-30Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30Q1 FY20262026-03-31Q2 FY20262026-06-30
Diluted shares (weighted)m shares36.6Diluted shares (weighted), Q3 FY2022, three months to 2022-09-3036,565,650 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2023-11-09, accession 0001213900-23-084970.Report this figure8.8Diluted shares (weighted), Q1 FY2023, three months to 2023-03-318,787,756 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2024-05-14, accession 0001213900-24-042805.Report this figure10.9Diluted shares (weighted), Q2 FY2023, three months to 2023-06-3010,921,239 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2024-08-13, accession 0001213900-24-067897.Report this figure11.0Diluted shares (weighted), Q3 FY2023, three months to 2023-09-3010,971,945 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2024-11-07, accession 0001213900-24-095173.Report this figure13.3Diluted shares (weighted), Q1 FY2024, three months to 2024-03-3113,334,900 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-05-12, accession 0001213900-25-042011.Report this figure15.0Diluted shares (weighted), Q2 FY2024, three months to 2024-06-3014,986,367 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-08-13, accession 0001213900-25-075635.Report this figure15.0Diluted shares (weighted), Q3 FY2024, three months to 2024-09-3015,000,516 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-11-10, accession 0001213900-25-107884.Report this figure15.0Diluted shares (weighted), Q1 FY2025, three months to 2025-03-3115,022,122 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-05-14, accession 0001213900-26-056595.Report this figure15.3Diluted shares (weighted), Q2 FY2025, three months to 2025-06-3015,333,962 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-08-14, accession 0001213900-26-089592.Report this figure16.6Diluted shares (weighted), Q3 FY2025, three months to 2025-09-3016,635,784 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-11-10, accession 0001213900-25-107884.Report this figure28.7Diluted shares (weighted), Q1 FY2026, three months to 2026-03-3128,671,819 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-05-14, accession 0001213900-26-056595.Report this figure28.7Diluted shares (weighted), Q2 FY2026, three months to 2026-06-3028,696,937 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-08-14, accession 0001213900-26-089592.Report this figure

Shares outstanding: 33.27mShares outstanding, period not labelled, at 2026-08-1033,274,561 shares. XBRL concept dei:EntityCommonStockSharesOutstanding. 10-Q filed 2026-08-14, accession 0001213900-26-089592.Report this figure at Aug 10, 2026, from the cover of the 10-Q filed Aug 14, 2026.

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:47 ET. Listed shows no prices and gives no investment advice.